Comparison of high‑performance liquid chromatography and ultraviolet‑visible spectrophotometry to determine the best method to assess Levofloxacin released from mesoporous silica microspheres/nano‑hydroxyapatite composite scaffolds

Wang,Qi; Wang,Guodong; Xie,Shicheng; Zhao,Xiaowei; Zhang,Yuanmin

doi:10.3892/etm.2019.7238

Comparison of high‑performance liquid chromatography and ultraviolet‑visible spectrophotometry to determine the best method to assess Levofloxacin released from mesoporous silica microspheres/nano‑hydroxyapatite composite scaffolds

Authors:
- Qi Wang
- Guodong Wang
- Shicheng Xie
- Xiaowei Zhao
- Yuanmin Zhang
View Affiliations

Affiliations: Department of Orthopedics, The Affiliated Hospital of Jining Medical University, Jining, Shandong 272000, P.R. China
Published online on: February 4, 2019 https://doi.org/10.3892/etm.2019.7238
Pages: 2694-2702
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

An assessment of Levofloxacin by high‑performance liquid chromatography (HPLC) or ultraviolet‑visible spectrophotometry (UV‑Vis) and its pharmacokinetics in serum or plasma was made in a previous study by the present authors. Levofloxacin‑loaded mesoporous silica microspheres/nano‑hydroxyapatite (n‑HA) composite scaffolds comprise a novel synthetic composite scaffold that may be utilized as a drug‑delivery system for clinical usage. However, few studies have been published concerning a comparison of HPLC with UV‑Vis, which is the preferred method for determination of Levofloxacin. In the present study, an HPLC method was first established, and subsequently a comparison of HPLC with the UV‑Vis method was performed. The standard curve was established, and recovery rate from simulated body fluid was calculated. The linear concentration range for Levofloxacin was 0.05‑300 µg/ml. The regression equation for HPLC was y=0.033x+0.010, with R2=0.9991, whereas that for UV‑Vis was y=0.065x+0.017, with R2=0.9999. The recovery rates of low, medium and high (5, 25 and 50 µg/ml) concentrations of Levofloxacin determined by HPLC were 96.37±0.50, 110.96±0.23 and 104.79±0.06%, respectively, whereas those for low, medium and high concentrations according to UV‑Vis were 96.00±2.00, 99.50±0.00 and 98.67±0.06%, respectively. Taken together, these findings demonstrated that it is not accurate to measure the concentration of drugs loaded on the biodegradable composite composites by UV‑Vis. HPLC is the preferred method to evaluate sustained release characteristics of Levofloxacin released from mesoporous silica microspheres/n‑HA composite scaffolds. The present study also provides guidance on which methods should be selected for investigating the sustained release properties of drugs in tissue engineering. The accurate determination of drug concentration in the drug delivery system provides guidance for the treatment of infectious diseases.

View Figures

View References

1	Das A, Mukherjee J, Dey G, Sarkar AK, Sahoo BK, Chakrabarty US, Nandi U and Pal TK: Bioequivalence study of levofloxacin tablets in healthy Indian volunteers using HPLC. Arzneimittelforschung. 61:61–65. 2011. View Article : Google Scholar : PubMed/NCBI
2	Wimer SM, Schoonover L and Garrison MW: Levofloxacin: A therapeutic review. Clin Ther. 20:1049–1070. 1998. View Article : Google Scholar : PubMed/NCBI
3	Carral N, Lukas JC, Oteo I and Suarez E: Impact of poor compliance with levofloxacin and moxifloxacin on respiratory tract infection antimicrobial efficacy: A pharmacokinetic/pharmacodynamic simulation study. Int J Antimicrob Agents. 45:79–83. 2015. View Article : Google Scholar : PubMed/NCBI
4	Sun H, Wang H and Ge X: Simultaneous determination of the combined drugs of ceftriaxone sodium, metronidazole, and levofloxacin in human urine by high-performance liquid chromatography. J Clin Lab Anal. 26:486–492. 2012. View Article : Google Scholar : PubMed/NCBI
5	Wang SS, Ratliff PD and Judd WR: Retrospective review of ceftriaxone versus levofloxacin for treatment of E.coli urinary tract infections. Int J Clin Pharm. 40:143–149. 2018. View Article : Google Scholar : PubMed/NCBI
6	Cicuéndsez M, Izquierdo-Barba I, Portolés MT and Vallet-Regí M: Biocompatibility and levofloxacin delivery of mesoporous materials. Eur J Pharm Biopharm. 84:115–124. 2013. View Article : Google Scholar : PubMed/NCBI
7	Croissant JG, Fatieiev Y, Almalik A and Khashab NM: Mesoporous silica and organosilica nanoparticles: Physical chemistry, biosafety, delivery strategies, and biomedical applications. Adv Healthc Mater. 7:2018.doi: 10.1002/adhm.201700831. View Article : Google Scholar
8	Shi S, Chen F and Cai W: Biomedical applications of functionalized hollow mesoporous silica nanoparticles: Focusing on molecular imaging. Nanomedicine (Lond). 8:2027–2039. 2013. View Article : Google Scholar : PubMed/NCBI
9	Guisasola E, Asín L, Beola L, de la Fuente JM, Baeza A and Vallet-Regí M: Beyond traditional hyperthermia: In vivo cancer treatment with magnetic-responsive mesoporous silica nanocarriers. ACS App Mater Interfaces. 10:12518–12525. 2018. View Article : Google Scholar
10	Wang Q, Chen C, Liu W, He X, Zhou N, Zhang D, Gu H, Li J, Jiang J and Huang W: Levofloxacin loaded mesoporous silica microspheres/nano-hydroxyapatite/polyurethane composite scaffold for the treatment of chronic osteomyelitis with bone defects. Sci Rep. 7:418082017. View Article : Google Scholar : PubMed/NCBI
11	Szerkus O, Jacyna J, Gibas A, Sieczkowski M, Siluk D, Matuszewski M, Kaliszan R and Markuszewski MJ: Robust HPLC-MS/MS method for levofloxacin and ciprofloxacin determination in human prostate tissue. J Pharm Biomed Anal. 132:173–183. 2017. View Article : Google Scholar : PubMed/NCBI
12	Gao XX, Yao GC, Guo N, An F and Guo XJ: A simple and rapid high performance liquid chromatography method to determine levofloxacin in human plasma and its use in a bioequivalence study. Drug Discov Ther. 1:136–140. 2007.PubMed/NCBI
13	Netz DJ, Sepulveda P, Pandolfelli VC, Spadaro AC, Alencastre JB, Bentley MV and Marchetti JM: Potential use of gelcasting hydroxyapatite porous ceramic as an implantable drug delivery system. Int J Pharm. 213:117–125. 2001. View Article : Google Scholar : PubMed/NCBI
14	Siewert S: Validation of a levofloxacin HPLC assay in plasma and dialysate for pharmacokinetic studies. J Pharm Biomed Anal. 41:1360–1362. 2006. View Article : Google Scholar : PubMed/NCBI
15	Arayne MS, Sultana N and Siddiqui FA: Optimization of levofloxacin analysis by RP-HPLC using multivariate calibration technique. Pak J Pharm Sci. 20:100–106. 2007.PubMed/NCBI
16	Lalitha Devi M and Chandrasekhar KB: A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant. J Pharm Biomed Anal. 50:710–717. 2009. View Article : Google Scholar : PubMed/NCBI
17	Argyo C, Weiss V, Bräuchle C and Bein T: Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery. Chemistry Materials. 26:435–451. 2014. View Article : Google Scholar
18	Sepulveda P, Binner JG, Rogero SO, Higa OZ and Bressiani JC: Production of porous hydroxyapatite by the gel-casting of foams and cytotoxic evaluation. J Biomed Mater Res. 50:27–34. 2000. View Article : Google Scholar : PubMed/NCBI
19	Ghaffar KA, Hussein WM, Khalil ZG, Capon RJ, Skwarczynski M and Toth I: Levofloxacin and indolicidin for combination antimicrobial therapy. Curr Drug Deliv. 12:108–114. 2015. View Article : Google Scholar : PubMed/NCBI
20	Guenter SG, Iven H, Boos C, Bruch HP and Muhl E: Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients. Pharmacotherapy. 22:175–183. 2002. View Article : Google Scholar : PubMed/NCBI
21	Langergraber G, Fleischmann N and Hofstädter F: A multivariate calibration procedure for UV/VIS spectrometric quantification of organic matter and nitrate in wastewater. Water Sci Technol. 47:63–71. 2003. View Article : Google Scholar : PubMed/NCBI
22	Nagaraja P, Al-Tayar NG, Shivakumar A, Shrestha AK and Gowda AK: A simple and sensitive spectrophotometric method for the determination of trace amounts of nitrite in environmental and biological samples using 4-amino-5-hydroxynaphthalene-2,7-disulphonic acid monosodium salt. Spectrochim Acta A Mol Biomol Spectrosc. 75:1411–1416. 2010. View Article : Google Scholar : PubMed/NCBI
23	Chamseddin C and Jira TH: Comparison of the chromatographic behavior of levofloxacin, ciprofloxacin and moxifloxacin on various HPLC phases. Pharmazie. 66:244–248. 2011.PubMed/NCBI
24	Nguyen HA, Grellet J, Ba BB, Quentin C and Saux MC: Simultaneous determination of levofloxacin, gatifloxacin and moxifloxacin in serum by liquid chromatography with column switching. J Chromatogr B Analyt Technol Biomed Life Sci. 810:77–83. 2004. View Article : Google Scholar : PubMed/NCBI
25	Watabe S, Yokoyama Y, Nakazawa K, Shinozaki K, Hiraoka R, Takeshita K and Suzuki Y: Simultaneous measurement of pazufloxacin, ciprofloxacin, and levofloxacin in human serum by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci. 878:1555–1561. 2010. View Article : Google Scholar : PubMed/NCBI
26	Ji HY, Jeong DW, Kim YH, Kim HH, Sohn DR and Lee HS: Hydrophilic interaction liquid chromatography-tandem mass spectrometry for the determination of levofloxacin in human plasma. J Pharm Biomed Anal. 41:622–627. 2006. View Article : Google Scholar : PubMed/NCBI
27	Borcan LC, Dudas Z, Len A, Fuzi J, Borcan F and Tomescu MC: Synthesis and characterization of a polyurethane carrier used for a prolonged transmembrane transfer of a chili pepper extract. Int J Nanomedicine. 6:7155–7166. 2018. View Article : Google Scholar
28	Rahimi S, Khoee S and Ghandi M: Development of photo and pH dual crosslinked coumarin-containing chitosan nanoparticles for controlled drug release. Carbohydr Polym. 201:236–245. 2018. View Article : Google Scholar : PubMed/NCBI